Statins and Research Bias
The discussion reveals a troubling landscape in medical research, particularly regarding statins, which are often promoted without full disclosure of their side effects. With significant funding from pharmaceutical companies, the integrity of clinical trials is called into question, as vital data remains inaccessible to independent researchers. The push for widespread statin use, especially among healthy individuals over 50, raises concerns about the validity of the underlying evidence and the potential for over-medication.In this clip
From this podcast
Paul Saladino MD podcast
STATINS: Should you take them?
Related Questions